NCT07688200Not yet recruiting

Treatment Registry of Arrhythmias, Complications and Electrocardiograms in Arrhythmogenic CardioMyopathies

Treatment Registry of Arrhythmias, Complications and Electrocardiograms in Arrhythmogenic CardioMyopathies: A Multicenter Retrospective Observational Study

Source: ClinicalTrials.gov · Last updated 7 Jul 2026

Brief summary (registry, in English)

TRACE-ACM is a multicenter, retrospective, observational study of patients with arrhythmogenic cardiomyopathy who received an implantable cardioverter-defibrillator (ICD) and had documented ventricular tachyarrhythmias. The study aims to describe the prevalence and type of ICD-related complications, characterize ventricular arrhythmias documented by ICD electrograms and/or ECG recordings, and explore associations between clinical, device-related, and treatment-related factors and arrhythmic outcomes.

Status (registry): Not yet recruiting
Study type: Observational
Enrollment: 300 (estimated)
First submitted: 23 Jun 2026
Start date: 1 Jul 2026
Primary completion date: 31 Dec 2027
Lead sponsor: Policlinico Casilino ASL RMB
NCT number: NCT07688200

What you commit to

Study type: Observational
Planned participants: 300
From 1 Jul 2026 to the primary completion date, 31 Dec 2027
No sites listed in no country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

Previous exposure to therapies associated with cardiac toxicity, including chemotherapy.

Other illness

Significant coronary artery disease, defined as coronary plaque greater than 50% at coronary angiography or coronary computed tomography angiography.
Primary valvular heart disease or congenital heart disease.

Other

Incomplete ICD data or incomplete ICD follow-up.
Infiltrative or inflammatory cardiomyopathies, including sarcoidosis or amyloidosis.

Who the study is looking for

Diagnosis of arrhythmogenic cardiomyopathy, including right-dominant arrhythmogenic right ventricular cardiomyopathy, biventricular arrhythmogenic cardiomyopathy, or left-dominant arrhythmogenic left ventricular cardiomyopathy.
ICD implantation.
Documented sustained ventricular tachyarrhythmia, including polymorphic ventricular tachycardia, ventricular fibrillation, or monomorphic ventricular tachycardia.
Periodic clinical and ICD follow-up.
Arrhythmia onset available from ICD electrograms and/or ECG recordings.
ECG/EGM tracings available for analysis by the steering ECG committee.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.